R3 Global — Execution
Funds global RNA biofoundry collaboration to speed vaccine and biologic development readiness.
R3 Global is the international scaling phase of Wellcome Leap's RNA manufacturing program, jointly funded by Wellcome Leap and CEPI (the Coalition for Epidemic Preparedness Innovations) with a combined investment of $60 million. The program's core thesis is that existing batch-production methods for RNA medicines are too slow and expensive to respond to pandemics or reach patients in low-income co…
Global distributed biofoundry network using continuous-flow manufacturing to produce RNA medicines faster and at lower cost, co-funded by Wellcome Leap and CEPI.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereDeep Tech Funding Playbook 2026
Data-driven guide for deeptech founders raising capital, covering valuations, investor expectations, fundraising tactics, and a map of 1,200+ deeptech funds.
Write proposalGrant Proposal Abstract and Executive Summary: Examples That Work
Learn how to write a grant proposal abstract or executive summary, what to include, how it differs from a project summary, and how to use examples without copying.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
Montana STEP Export Grant
🇺🇸MT Commerce · United States
Funds Montana small businesses exporting deep-tech products internationally through reimbursement of trade shows, compliance testing, IP filings, e-commerce, and market research costs.
R&D Tax Credit — Income Tax Credit (Section 41) — TY2025 / Filed
🇺🇸IRS · United States
Supports established United States companies with income tax credits tied to qualified innovation spending.
NIMHD SBIR/STTR Commercialization Readiness Pilot
🇺🇸NIMHD · United States
Funds NIH-funded small businesses moving SBIR or STTR projects from late-stage development to commercialization.
R&D Tax Credit — QSB Payroll Offset (Section 41) — TY2025 / Filed
🇺🇸IRS · United States
Supports United States small businesses through payroll tax offsets when they fund qualifying innovation activity.
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience
🇺🇸NIH · United States
Funds a minority-serving or IDeA-eligible institution to build a facility that makes and ships brain cell-targeting reagents to neuroscience labs.
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.